Related references
Note: Only part of the references are listed.Antiosteoporotic Activity of Genistein Aglycone in Postmenopausal Women: Evidence from a Post-Hoc Analysis of a Multicenter Randomized Controlled Trial
Vincenzo Arcoraci et al.
NUTRIENTS (2017)
Visfatin correlates with hot flashes in postmenopausal women with metabolic syndrome: effects of genistein
Alessandra Bitto et al.
ENDOCRINE (2017)
High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy
Antoinette Bugyei-Twum et al.
CARDIOVASCULAR DIABETOLOGY (2014)
EFFECT OF AN EDUCATIONAL PROGRAM IN PRIMARY CARE: THE CASE OF LIPID CONTROL IN CARDIO-CEREBRO VASCULAR PREVENTION
V. Arcoraci et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2014)
Impact of metabolic syndrome on the risk of atrial fibrillation recurrence after catheter ablation: systematic review and meta-analysis
Kueiyu Joshua Lin et al.
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2014)
Pattern of Statin Use in Southern Italian Primary Care: Can Prescription Databases Be Used for Monitoring Long-Term Adherence to the Treatment?
Carmen Ferrajolo et al.
PLOS ONE (2014)
Mechanisms of Adverse Cardiometabolic Consequences of Obesity
Carlos M. Diaz-Melean et al.
CURRENT ATHEROSCLEROSIS REPORTS (2013)
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Lars Ryden et al.
EUROPEAN HEART JOURNAL (2013)
Genistein and endothelial function in postmenopausal women with metabolic syndrome
Concetta Irace et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
Genistein in the Metabolic Syndrome: Results of a Randomized Clinical Trial
Francesco Squadrito et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Role of adipokines in cardiovascular disease
Harman S. Mattu et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Visfatin/Nampt: An Adipokine with Cardiovascular Impact
Tania Romacho et al.
MEDIATORS OF INFLAMMATION (2013)
The Steady-State Serum Concentration of Genistein Aglycone Is Affected by Formulation: A Bioequivalence Study of Bone Products
Alessandra Bitto et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Adipokines and the cardiovascular system: mechanisms mediating health and disease
Josette M. Northcott et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2012)
Cardiovascular and Metabolic Regulation by the Adiponectin/C1q/Tumor Necrosis Factor-Related Protein Family of Proteins
Noriyuki Ouchi et al.
CIRCULATION (2012)
Estrogen Receptors: Therapies Targeted to Receptor Subtypes
S. Nilsson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Estrogen, hormonal replacement therapy and cardiovascular disease
Xiao-Ping Yang et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2011)
Current and Evolving Echocardiographic Techniques for the Quantitative Evaluation of Cardiac Mechanics: ASE/EAE Consensus Statement on Methodology and Indications Endorsed by the Japanese Society of Echocardiography
Victor Mor-Avi et al.
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY (2011)
Update in Hormone Therapy Use in Menopause
Hugh S. Taylor et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Epidemiology of the metabolic syndrome in the USA
Arthur J. McCullough
JOURNAL OF DIGESTIVE DISEASES (2011)
The homocysteine hypothesis: Still relevant to the prevention and treatment of cardiovascular disease?
Joellyn M. Abraham et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2010)
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study
H. Marini et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2010)
Genistein aglycone: A new therapeutic approach to reduce endometrial hyperplasia
Alessandra Bitto et al.
PHYTOMEDICINE (2010)
Estrogen and Mechanisms of Vascular Protection
Dongqi Xing et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Impaired atrial synchronicity in patients with metabolic syndrome associated with insulin resistance and independent of hypertension
Shao-Hua Li et al.
HYPERTENSION RESEARCH (2009)
Evidence-Based Knowledge Management: an approach to effectively promote good health-care decision-making in the Information Era
Salvatore Corrao et al.
INTERNAL AND EMERGENCY MEDICINE (2009)
The metabolic syndrome: A critical appraisal based on the CUORE epidemiologic study
Simona Giampaoli et al.
PREVENTIVE MEDICINE (2009)
Menopause and the metabolic syndrome - The Study of Women's Health Across the Nation
Imke Janssen et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision
G. Trifiro et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Statins for the primary prevention of cardiovascular events in elderly patients: A picture from clinical practice without strong evidence from clinical trials
Gianluca Trifiro et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
Adipokines and Insulin Resistance
Katja Rabe et al.
MOLECULAR MEDICINE (2008)
The effect of the phytoestrogen genistein on myocardial protection, preconditioning and oxidative stress
Eftihia Sbarouni et al.
CARDIOVASCULAR DRUGS AND THERAPY (2006)
Recommendations for chamber quantification
Roberto M. Lang et al.
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY (2006)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Adiponectin, the missing link in insulin resistance and obesity
M Gil-Campos et al.
CLINICAL NUTRITION (2004)
The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study
E Bonora et al.
DIABETIC MEDICINE (2004)
Phytoestrogenic isoflavones daidzein and genistein reduce glucose-toxicity-induced cardiac contractile dysfunction in ventricular myocytes
KK Hintz et al.
ENDOCRINE RESEARCH (2004)
Sex hormone levels and risk of cardiovascular events in postmenopausal women
KM Rexrode et al.
CIRCULATION (2003)
Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin
PJ Havel
CURRENT OPINION IN LIPIDOLOGY (2002)
Share Paper
